By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Omrix Biopharmaceuticals, Inc. 

630 5th Avenue
22nd Floor
New York  New York  10111  U.S.A.
Phone: 212-887-6500 Fax: 212-887-6550


SEARCH JOBS








Company News
Macrocure Taps Ex-Omrix Biopharmaceuticals, Inc. (OMRI) President, Nissim Mashiach as New President & CEO 6/13/2012 7:24:00 AM
Johnson & Johnson (JNJ) Completes Omrix Biopharmaceuticals, Inc. (OMRI) Tender Offer 12/29/2008 8:02:49 AM
Johnson & Johnson (JNJ) Extends Tender Offer for Omrix Biopharmaceuticals, Inc. (OMRI) 12/22/2008 10:15:10 AM
Johnson & Johnson (JNJ) Announces Receipt of Israeli Antitrust Approval for Acquisition of Omrix Biopharmaceuticals, Inc. (OMRI) 12/12/2008 9:52:34 AM
Johnson & Johnson (JNJ) (JOBS) Acquire Omrix Biopharmaceuticals, Inc. (OMRI) for $438 Million 11/24/2008 6:25:17 AM
Omrix Biopharmaceuticals, Inc. (OMRI) Shares Gain Ground Monday On Buyout Speculation 11/11/2008 7:37:24 AM
Omrix Biopharmaceuticals, Inc. (OMRI) Announces Third Quarter 2008 Financial Results 11/6/2008 11:12:28 AM
Omrix Biopharmaceuticals, Inc. (OMRI) to Webcast Presentation at Rodman & Renshaw Annual Healthcare Conference 11/4/2008 9:06:02 AM
Omrix Biopharmaceuticals, Inc. (OMRI) Reschedules its Third Quarter 2008 Financial Results and Conference Call to an Earlier Time on November 6, 2008 11/3/2008 10:10:46 AM
Omrix Biopharmaceuticals, Inc. (OMRI) to Resume U.S. Trials of Anti-Bleeding Product 10/27/2008 7:13:50 AM
12345678910...
//-->